SNSE

Sensei Biotherapeutics, Inc.

Investor Moves

NameValueActionChangePriceLast Price
Jim SimonsRenaissance Technologies
$1M32k shares
AddQ1 2026
$887k
$31.52
$13.85
Jim SimonsRenaissance Technologies
$24.4K
AddQ4 2025
$24k
--
$13.85

Insider Trades

NameValueActionPriceLast Price
Peyer James10 Percent Owner, Other: See Remarks Below
$490k24.5k shares
SellJun 1, 2026
$20.00
$13.85
Cambrian BioPharma Inc10 Percent Owner
$490k24.5k shares
SellJun 1, 2026
$20.00
$13.85
Peyer James10 Percent Owner, Other: See Remarks Below
$10k476 shares
SellJun 1, 2026
$21.14
$13.85
Cambrian BioPharma Inc10 Percent Owner
$10k476 shares
SellJun 1, 2026
$21.14
$13.85
Millennium Management LLC10 Percent Owner
$280k10.6k shares
BuyMar 27, 2026
$26.29
$13.85
Millennium Management LLC10 Percent Owner
$1.4k45 shares
SellApr 6, 2026
$31.96
$13.85

News

businesswire.comSensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancerbusinesswire.comJun 15gurufocus.comSensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)gurufocus.comJun 4businesswire.comSensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)businesswire.comJun 4gurufocus.comSensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updategurufocus.comMay 15businesswire.comSensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updatebusinesswire.comMay 15